RMC-4630
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RMC-4630, covering 2025-01-24 to 2026-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies [Phase 2]